Central effects of fexofenadine and cetirizine: measurement of psychomotor performance, subjective sleepiness, and brain histamine H1-receptor occupancy using 11C-doxepin positron emission tomography.

Central effects of fexofenadine and cetirizine: measurement of psychomotor performance, subjective sleepiness, and brain histamine H1-receptor occupancy using 11C-doxepin positron emission tomography.

Item

http://www.wikidata.org/entity/Q34337549

Q34337549

about

Bilastine vs. hydroxyzine: occupation of brain histamine H1 -receptors evaluated by positron emission tomography in healthy volunteers Pharmacology of antihistamines Treatment of allergic rhinitis and urticaria: a review of the newest antihistamine drug bilastine Repeated-dose effects of mequitazine, cetirizine and dexchlorpheniramine on driving and psychomotor performance Central nervous system effects of the second-generation antihistamines marketed in Japan--review of inter-drug differences using the proportional impairment ratio (PIR)-Histamine H1 receptor antagonist cetirizine impairs working memory processing speed, but not episodic memory.Pharmacology of antihistamines.Histamine H₁ receptor occupancy by the new-generation antidepressants fluvoxamine and mirtazapine: a positron emission tomography study in healthy volunteers.Fexofenadine: biochemical, pharmacokinetic and pharmacodynamic properties and its unique role in allergic disorders.Evaluating the Anti-nociceptive and Anti-inflammatory Effects of Ketotifen and Fexofenadine in Rats.Effects of single therapeutic doses of promethazine, fexofenadine and olopatadine on psychomotor function and histamine-induced wheal- and flare-responses: a randomized double-blind, placebo-controlled study in healthy volunteers H1 antihistamines: current status and future directions.Pharmacokinetics, Pharmacodynamics and Population Pharmacokinetic/Pharmacodynamic Modelling of Bilastine, a Second-Generation Antihistamine, in Healthy Japanese Subjects.Drug metabolism and pharmacokinetics.From pharmacokinetics to therapeutics.Histamine, histamine receptors and antihistamines: new concepts.Positron emission tomography evaluation of sedative properties of antihistamines.Pharmacological rationale for the treatment of chronic urticaria with second-generation non-sedating antihistamines at higher-than-standard doses.Safety and efficacy of bilastine: a new H(1)-antihistamine for the treatment of allergic rhinoconjunctivitis and urticaria.Full efficacy with no CNS side-effects: unachievable panacea or reality? DMPK considerations in design of drugs with limited brain penetration.Chronic urticaria: a comparison of management guidelines.(11) C-labeled and (18) F-labeled PET ligands for subtype-specific imaging of histamine receptors in the brain.Assessment of the first and second generation antihistamines brain penetration and role of P-glycoprotein.Brain histamine H1 receptor occupancy of orally administered antihistamines, bepotastine and diphenhydramine, measured by PET with 11C-doxepin Brain histamine H receptor occupancy of orally administered antihistamines measured by positron emission tomography with (11)C-doxepin in a placebo-controlled crossover study design in healthy subjects: a comparison of olopatadine and ketotifen.H1 receptor-mediated vasodilatation contributes to postexercise hypotension.A simulated car-driving study on the effects of acute administration of levocetirizine, fexofenadine, and diphenhydramine in healthy Japanese volunteers.Assessment of the effects of antihistamine drugs on mood, sleep quality, sleepiness, and dream anxiety.Brain histamine H1 receptor occupancy measured by PET after oral administration of levocetirizine, a non-sedating antihistamine.Cetirizine in horses: pharmacokinetics and effect of ivermectin pretreatment.Pharmacology of Antihistamines

P2860

Q24563637-5DED3ACC-1BEB-44F0-BE5B-D4819903295B Q24618798-5909E0A0-28DE-46DD-826A-F664D4057C78 Q26750723-30AE8965-92E7-4664-8705-B1A376E220F8 Q28289605-7E6ACFB7-41BA-43A0-B52D-51098B449D0A Q28542698-F4EDC7B2-C506-404D-93BD-5661C702DD32 Q34339795-20D63D1F-839C-4DEB-9631-AB93B34BCD13 Q34347782-B352566A-33E6-43CE-8F26-6CB0C54F2830 Q34348107-C753DD84-D957-49E2-8A3F-B785EF6CE1DC Q34988193-F166B880-40A1-4B30-8946-B88DC97F393B Q35895241-31B8E13C-A589-441A-A52A-C6F578C38A47 Q35904482-91D2674A-7276-40F6-B73C-54C10B94811B Q36834344-782E80B0-C776-4DED-A878-EB7D6B3C6CE9 Q37410744-A489E054-6C50-4C14-AFBE-007761D06AB1 Q37550548-E8E93390-FA1B-4092-8909-004BC147E786 Q37550564-785A20F0-7250-4736-A54B-37C60DA87C48 Q37762461-5462CA52-F430-4723-8544-6BB0490B2E68 Q37869149-3169A8C5-EAA1-4890-B1AA-8405CF00D926 Q37907381-EC6BF842-9475-43EC-B8ED-89A4FDB28275 Q37914886-F84630E8-6551-42D7-B332-78447C82E60C Q37942267-48C83A53-67B7-486E-9855-3F6544950FDB Q37950484-778EAFDA-B30D-4B9C-AA18-9E4429D7F334 Q38166967-EEAAD3FA-BD8A-4138-98FF-3A319AF960B8 Q40192152-B4024924-DD38-4533-8D4E-5BCED22B687B Q40943347-E21464EE-DC67-4081-97A3-A8F083F2AFC0 Q41813382-1631C25A-B0A0-43D6-8144-D6CCF58CD216 Q45200705-D166F948-BEA6-4A5B-BB1F-1CD738CA417D Q47450319-40AD3791-27E5-4636-B6D9-A60E613C27F2 Q47897758-D247B020-5408-4629-9924-757AAFAAC4FD Q48010806-91E155DF-5FF0-4321-AFDC-9AE5F7DB8C90 Q52679436-9B958DF7-BE99-4264-9FFC-B3667BBB16AC Q56536196-0D4BE713-3409-4494-ADF7-241CCD9E3BCF

P2860

Central effects of fexofenadine and cetirizine: measurement of psychomotor performance, subjective sleepiness, and brain histamine H1-receptor occupancy using 11C-doxepin positron emission tomography.

Item

http://www.wikidata.org/entity/Q34337549

description

2004 nî lūn-bûn

@nan

2004 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2004 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2004年の論文

@ja

2004年論文

@yue

2004年論文

@zh-hant

2004年論文

@zh-hk

2004年論文

@zh-mo

2004年論文

@zh-tw

2004年论文

@wuu